HBI Deals+Insights / Digital and AI
London-based Flo Health, a menstrual cycle and ovulation tracking app, has raised over $200 million in a Series C round led by General Atlantic, a New-York based private equity firm. The funding values Flo at over $1 billion, making it the “first purely digital consumer women’s health app to achieve unicorn status”, as well as the first European femtech company to.